Home News

Payments totalling US$500k awarded in global Brucellosis Vaccine Prize competition

EDINBURGH, UK, September 26, 2017 – Additional prizes have been awarded in a global US $30 million competition aimed at incentivising the development of a vaccine that is efficacious, safe and viable for use against Brucella melitensis in small ruminants across the developing world. Five organisations will each receive US $100,000 following their initial application.  […]

Statement on anti-microbial resistance

The availability and use of antimicrobial medicines has transformed the practice of human and animal medicine. Infections that were once lethal are now treatable, and the use of antimicrobial drugs has advanced global health as well as animal health, which is a key component of policies to improve animal welfare, food security and food safety. […]

Brucellosis outbreak in India highlights need for greater disease control

A fresh outbreak of brucellosis in India serves as a stark reminder of the need for effective control measures. In July, more than 50 cows were reported to have been infected with brucellosis in the town of Tirumala. This follows a similar outbreak in February, during which a dozen cows contracted the disease. The infected […]

GALVmed delivers goat rearing training in India

GALVmed’s Market Development & Access (MD&A) department in South Asia has been working with the Jeevika Trust recently to deliver training in goat rearing in Bihar, India. The trust was aware of GALVmed’s work and its expertise in animal health and management. It approached the organisation through the Aga Khan Foundation (AKF) to train their officials on goat health […]

First competition payments in global Brucellosis Vaccine Prize competition

Prizes awarded to three organisations at the midway point of Phase 1 EDINBURGH, UK, July 6, 2017 – Three organisations have each been awarded prizes of US $100,000 following their initial application to the Brucellosis Vaccine Prize – a global US $30 million competition aimed at incentivising the development of a new Brucella melitensis vaccine. […]

AgResults’ US $30 million Brucellosis Vaccine Prize on the agenda at Global Sheep Veterinary Congress

        Release date: 24 May 2017 EDINBURGH, UK, May 24, 2017 – Small ruminant experts attending this month’s International Sheep Veterinary Congress in Harrogate are being encouraged to enter a US $30 million prize competition to develop a brucellosis vaccine to improve the livelihoods of smallholder farmers in developing countries. The Brucellosis […]

OIE & GALVmed team up to promote harmonised registration of veterinary drugs in the SADC region

(Johannesburg, 11 May 2017) In a globalising world where clusters of countries increasingly face the same challenges and seek closer cooperation to deal with these issues together, great gains can be made by harmonising approaches to problem solving and avoiding duplication of efforts among countries in the same region. One such area is the registration of […]

ViroVet and GALVmed to collaborate on novel vaccines for sheep & goats

LEUVEN, Belgium, May 17th, 2017 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce a collaboration with GALVmed. Under the collaboration, ViroVet will extend its vaccine pipeline to include novel vaccines for small ruminants. Since its capital increase in December […]

Researchers on a mission to improve the East Coast Fever vaccine

(15th February 2015) GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection and Treatment Method (ITM)  was developed in mid-70s and since then new tools have been developed   to characterise the vaccine strains/stocks and provide new knowledge […]

Applications now open for AgResults’ Global US $30 Million Brucellosis Vaccine Prize

FOR IMMEDIATE RELEASE November 18, 2016 Press Office: +44 (0)20 8647 4467 Email: nic.daley@garnettkeeler.com Additional press contacts below   Competition aims to incentivize vaccine development breakthrough EDINBURGH, UK, November 18, 2016 – A US $30 million prize competition to develop a brucellosis vaccine to improve the livelihoods of smallholder farmers in developing countries is now […]

1 2 3 19